Teleflex | TFX - 销售收入



金融业
股票价格
USD
资产
USD 6.95B
现金及等价物
USD 354M
销售成本
USD 261.54M
流动资产
USD 1.94B
流动负债
USD 762.03M
债务
USD 2.77B
股息收益率
1.11
EBIT
USD 36.34M
EBITDA
USD -328.81M
员工
14.1K
EPS每股收益
USD 1.93
股本和储备
USD 3.12B
销售毛利
USD 307.45M
债务利息支出
USD 28.15M
利息收入
USD -9.24
贷款资金
USD 2.54B
市值
USD 6.38B
净收入
USD -714.33M
营业费用
USD 532.64M
营业利润
USD 36.34M
普通股股本
USD 44.19M
PE价格收益
27.79
税前利润
USD -438.58M
销售收入
USD 568.98M
销售和管理费用
USD 222.37M
股票
USD 802.47M
贸易债权人
USD 130.2M
应收帐款人
USD 345.58M


销售 更改 日
Abbott USD 11.16B 300M 2026-03
Align Technology USD 1.04B 10M 2026-03
AngioDynamics USD 79.43M 3.72M 2025-09
AtriCure USD 140.5M 6.2M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
General Electric Aerospace USD 11.6B 270M 2026-03
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Orthofix International USD 219.91M 14.28M 2025-12
ResMed USD 1.4B 100M 2025-12
Steris USD 1.5B 470M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03